Precision oncology company Guardant Health, Inc. has announced the appointment of Musa Tariq to its board of directors, effective March 6.
Guardant Health focuses on helping conquer cancer globally through use of its proprietary tests, large data sets and advanced analytics.
Tariq is currently chief marketing officer of fundraising platform, GoFundMe.
Helmy Eltoukhy, Guardant Health chairman and co-CEO, said:
“We are very pleased to welcome Musa Tariq to our board of directors.
“Musa brings a wealth of knowledge and expertise in building some of the world’s most recognised brands.
“His insights will be extremely valuable as we continue to build our brand and shape the company’s next chapter to empower every individual to stay one step ahead of cancer.”
Since joining GoFundMe in January 2021, Tariq featured in Forbes’ Entrepreneurial CMO List 2022, and in Insider’s Most Innovative CMOs of 2022.
Before joining GoFundMe, Tariq was global head of marketing for Airbnb Experiences where he drove brand awareness and adoption of that rapidly growing part of Airbnb’s business.
Prior to Airbnb, Tariq was chief brand officer at Ford Motor Company and also held marketing leadership roles at Apple, Nike and Burberry.
“I am excited to join the Guardant Health board at such a pivotal time in the company’s evolution.
“Guardant is a leader in helping patients at all stages of cancer live longer and healthier lives, and now they’ve developed a simple blood test to find cancer early, when it’s most treatable.
“I look forward to working with the company’s leadership team to advance its mission to transform the future of cancer care.”
Healthcare innovators and leaders honoured at Imprivata HealthCon user group and awards ceremony
Wearable communication system may reduce digital health divide
Molecule trains the immune system to prevent cancer
Diabetes patients urged to use fitness games with caution
Urgent work needed to tackle ‘substantial’ digital health inequality
eSight: “The technology has the potential to change someone’s life”
Microsoft invests £2.5 billion in UK AI
TMS shows promise in tackling depression ‘epidemic’
AI depression app set for NHS clinical trial
UK Biobank releases world’s largest single set of sequencing data
- News3 weeks ago
Why a leading healthcare CEO sees recombinant DNA as a metaphor for developing breakthrough technologies
- AI6 days ago
AI model predicts breast cancer risk without racial bias
- Medtech4 weeks ago
Surtex Instruments to unveil game-changing Infinex microsurgery instruments at MEDICA
- AI2 weeks ago
Humans make better cancer treatment decisions than AI, study finds